Browse > Article
http://dx.doi.org/10.4333/KPS.2008.38.1.057

Determination of saikosaponin derivatives in Bupleuri Radix using HPLC-ELSD  

Kim, Bo-Mi (College of Pharmacy, Seoul National University)
Yoon, Kee-Dong (College of Pharmacy, Seoul National University)
Han, Kyung-Reem (College of Pharmacy, Seoul National University)
Kim, Jin-Woong (College of Pharmacy, Seoul National University)
Publication Information
Journal of Pharmaceutical Investigation / v.38, no.1, 2008 , pp. 57-61 More about this Journal
Abstract
A HPLC-ELSD method was developed to determine saikosaponin derivatives from Bupleuri Radix. Eight saikosaponins, saikosaponin c, i, h, a, $b_2$, g, $b_1$ and d, were analyzed under optimized HPLC conditions [column: Eclipse XDB $C_{18}$ ($150{\times}4.6mm$ i.d., $5{\mu}m$; mobile phase: $H_2O$ with 0.1% $CH_3$COOH (v/v) for solvent A and AcCN with 0.1% $CH_3$COOH (v/v) for solvent B, gradient elution; flow rate: 1mL/min; injection volume: $20{\mu}L$]. Good linearity was achieved in the range from 62.5 to $250{\mu}g/mL$ for each compound, and intra-day precision and accuracy at each concentration level varied between 0.05 and 5.45% and between 93.9 and 109.6%, respectively, whereas those for inter-day variations were between 0.91 to 2.73% and 94.3 to 106.1%. This HPLC-ELSD method was applied for the determination of sakosaponins from Bupleuri Radix samples, and saikosaponin a $(0.79{\pm}0.20mg/g)$, c $(0.33{\pm}0.06mg/g)$ and d $(0.48{\pm}0.15mg/g)$ were observed as major compounds. The other saikosaponins were shown under limit of quantification level thus couldn't be quantified. The present study suggested that the introduced HPLC-ELSD method is selective and reliable, and not only saikosaponin a, but also saikosaponin c and d should be employed as the standard markers for Bupleuri Radix.
Keywords
Bupleuri Radix; HPLC-ELSD method; saikosaponin a; c and d;
Citations & Related Records
연도 인용수 순위
  • Reference
1 K. Tori, S. Seo, Y. Yoshimura, M. Nakamura, T. Yutaka and H. Ishii, Carbon -13 NMR spectra of saikosaponin A, C, D and F isolated from Bupleurum falcatum L. Tetrahedron Lett., 46, 4167-4170 (1976)
2 L. Liu, Y. Cheng and H. Zhang, Phytochemical analysis of anti-athrogenic constituents of Xue-Fu-Zhu-Yu-Tang using HPLC-DAD-ESI-MS. Chem. Pharm. Bull., 52, 1295-1301 (2004)   DOI   ScienceOn
3 L.C. Chiang, L.T. Ng, L.T. Liu, D.E. Shieh and C.C. Lin, Cytotoxicity and anti-hepatitis B virus activities of saikosaponins from Bupleurum species. Planta Med., 69, 705-709 (2003)   DOI   ScienceOn
4 대한약정 8개정 의약품 각조 제 2부
5 H. Ishii, M. Nakamura, S. Seo, K. Tori, T. Tozyo and Y. Yoshimura, Isolation, characterization, and nuclear magnetic resonance spectra of new saponins from the roots of Bupleurum falcatum L. Chem. Pharm. Bull., 28, 2367-2383 (1980)   DOI
6 A. Shimaoka, S. Seo and H. Minato, Saponins isolated from Bupleurum falcatum L.; Components of saikosaponin-B. J. Chem. Soc. Perkin Trans. I, 2043-2048a (1975)
7 T. Kuboata and H. Hinoh, The constitution of saponins isolated from Bupleurum falcatum L. Tetrahedron Lett., 9, 303-306 (1967)
8 K. Bae, The Medicinal Plants of Korea, Kyo-Hak, Seoul, Korea, p. 372 (1999)
9 H. Kohno, M. Yamazaki, N. Jyumonji, N. Yamaguchi and S. Odashima, An investigation of the immune suppression induced by some saikosaponin derivatives. Int. J. Immunopharmacol., 10, 845-850 (1998).   DOI   ScienceOn
10 P. Bermejo Benito, M.J. Abad Martnez, A.M. Silvn Sen, A. Sanz Gmez, L. Fernndez Matellano, S. Snchez Contreras and A.M. Diaz Lanza, In vivo and in vitro antiinflammatory activity of saikosaponins. Life Sci., 63, 1147-1156 (1998)   DOI   ScienceOn
11 H. Ishii, S. Seo, K. Tori, T. Tozyo and Y. Yoshimura, The structure of saikosaponin-E and acetylsaikosaponins, minor components isolated from Bupleurum falcatum L., determined by C-13 NMR spectroscopy. Tetrahedron Lett., 18, 1227-1230 (1977)   DOI   ScienceOn
12 L. Pistelli, A. Cammilli, A. Manunta, A. Marsili and I. Morelli, Triterpenoid saponins and flavonoid glycoside from Bupleurum falcatum subsp. cernuum. Phytochemistry, 33, 1537-1359 (1993)   DOI   ScienceOn
13 N. Ebata, H. Nakajima, K. Hayashi, M. Okada and M. Maruno, Saponins from the root of Bupleurum falcatum. Phytochemistry, 41, 895-901 (1996)   DOI   ScienceOn
14 J.C. Chen, N.W. Chang, J.G. Chung and K.C. Chen, Saikosaponin-A induces apoptotic mechanism in human breast MDA-MB-231 and MCF-7 cancer cells. Am. J. Chin. Med., 31, 363-377 (2003)   DOI   ScienceOn
15 W.S. Wu and H.Y. Hsu, Involvement of p-51INK4band p- 16INK4a gene expression in saikosaponin a and TPAinduced growth inhibition of HepG2 cells. Biochem. Biophys. Res. Commun., 285, 183-187 (2001)   DOI   ScienceOn
16 Y.L. Hsu, P.L. Kuo and C.C. Lin, The proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells. Life Sci., 75, 1231-1242 (2004)   DOI   ScienceOn
17 N. Yamaguchi, H. Kohno, M. Tawara and S. Odashima, Effect of saikosaponin derivatives upon the immune response against T-dependent and T-independent antigens in mice. Int. J. Immunopharmacol., 7, 827-832 (1985)   DOI   ScienceOn
18 B.C. Liau, S.S. Hsiao, M.R. Lee, T.T. Jong and S.T. Chiang, Quality control of Chinese medicinal preparations LC/ ESI(+)/MS/MS analyses of saikosaponin-a and -c as markers of Bupleuri redix samples. J. Pharm. Biomed. Anal., 43, 1174-1178 (2007)   DOI   ScienceOn